Global Icodec Insulin Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
Icodec Insulin is a long-acting insulin analog that is widely used in basal insulin therapy for patients with type 1 and type 2 diabetes. Its structure has been modified so that it forms microcrystals after subcutaneous injection, gradually releasing insulin and providing stable blood sugar control for up to 24 hours. This long-acting property reduces the risk of hypoglycemia, especially the incidence of nocturnal hypoglycemia. Icodec Insulin usually only needs to be injected once a day, and its stable efficacy can maintain blood sugar balance throughout the day regardless of when it is injected.
The global Icodec Insulin market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Icodec Insulin Industry Forecast” looks at past sales and reviews total world Icodec Insulin sales in 2023, providing a comprehensive analysis by region and market sector of projected Icodec Insulin sales for 2024 through 2030. With Icodec Insulin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Icodec Insulin industry.
This Insight Report provides a comprehensive analysis of the global Icodec Insulin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Icodec Insulin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Icodec Insulin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Icodec Insulin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Icodec Insulin.
United States market for Icodec Insulin is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Icodec Insulin is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Icodec Insulin is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Icodec Insulin players cover Novo Nordisk, Lilly, Sanofi, Paijin Biotechnology, Gan&Lee Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Icodec Insulin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Icodec Insulin market?
What factors are driving Icodec Insulin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Icodec Insulin market opportunities vary by end market size?
How does Icodec Insulin break out by Type, by Application?
Icodec Insulin is a long-acting insulin analog that is widely used in basal insulin therapy for patients with type 1 and type 2 diabetes. Its structure has been modified so that it forms microcrystals after subcutaneous injection, gradually releasing insulin and providing stable blood sugar control for up to 24 hours. This long-acting property reduces the risk of hypoglycemia, especially the incidence of nocturnal hypoglycemia. Icodec Insulin usually only needs to be injected once a day, and its stable efficacy can maintain blood sugar balance throughout the day regardless of when it is injected.
The global Icodec Insulin market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “Icodec Insulin Industry Forecast” looks at past sales and reviews total world Icodec Insulin sales in 2023, providing a comprehensive analysis by region and market sector of projected Icodec Insulin sales for 2024 through 2030. With Icodec Insulin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Icodec Insulin industry.
This Insight Report provides a comprehensive analysis of the global Icodec Insulin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Icodec Insulin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Icodec Insulin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Icodec Insulin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Icodec Insulin.
United States market for Icodec Insulin is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Icodec Insulin is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Icodec Insulin is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Icodec Insulin players cover Novo Nordisk, Lilly, Sanofi, Paijin Biotechnology, Gan&Lee Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Icodec Insulin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Long-acting
- Medium-acting
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novo Nordisk
- Lilly
- Sanofi
- Paijin Biotechnology
- Gan&Lee Pharmaceuticals
What is the 10-year outlook for the global Icodec Insulin market?
What factors are driving Icodec Insulin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Icodec Insulin market opportunities vary by end market size?
How does Icodec Insulin break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Icodec Insulin Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Icodec Insulin by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Icodec Insulin by Country/Region, 2019, 2023 & 2030
2.2 Icodec Insulin Segment by Type
2.2.1 Long-acting
2.2.2 Medium-acting
2.3 Icodec Insulin Sales by Type
2.3.1 Global Icodec Insulin Sales Market Share by Type (2019-2024)
2.3.2 Global Icodec Insulin Revenue and Market Share by Type (2019-2024)
2.3.3 Global Icodec Insulin Sale Price by Type (2019-2024)
2.4 Icodec Insulin Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Icodec Insulin Sales by Application
2.5.1 Global Icodec Insulin Sale Market Share by Application (2019-2024)
2.5.2 Global Icodec Insulin Revenue and Market Share by Application (2019-2024)
2.5.3 Global Icodec Insulin Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Icodec Insulin Breakdown Data by Company
3.1.1 Global Icodec Insulin Annual Sales by Company (2019-2024)
3.1.2 Global Icodec Insulin Sales Market Share by Company (2019-2024)
3.2 Global Icodec Insulin Annual Revenue by Company (2019-2024)
3.2.1 Global Icodec Insulin Revenue by Company (2019-2024)
3.2.2 Global Icodec Insulin Revenue Market Share by Company (2019-2024)
3.3 Global Icodec Insulin Sale Price by Company
3.4 Key Manufacturers Icodec Insulin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Icodec Insulin Product Location Distribution
3.4.2 Players Icodec Insulin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ICODEC INSULIN BY GEOGRAPHIC REGION
4.1 World Historic Icodec Insulin Market Size by Geographic Region (2019-2024)
4.1.1 Global Icodec Insulin Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Icodec Insulin Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Icodec Insulin Market Size by Country/Region (2019-2024)
4.2.1 Global Icodec Insulin Annual Sales by Country/Region (2019-2024)
4.2.2 Global Icodec Insulin Annual Revenue by Country/Region (2019-2024)
4.3 Americas Icodec Insulin Sales Growth
4.4 APAC Icodec Insulin Sales Growth
4.5 Europe Icodec Insulin Sales Growth
4.6 Middle East & Africa Icodec Insulin Sales Growth
5 AMERICAS
5.1 Americas Icodec Insulin Sales by Country
5.1.1 Americas Icodec Insulin Sales by Country (2019-2024)
5.1.2 Americas Icodec Insulin Revenue by Country (2019-2024)
5.2 Americas Icodec Insulin Sales by Type (2019-2024)
5.3 Americas Icodec Insulin Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Icodec Insulin Sales by Region
6.1.1 APAC Icodec Insulin Sales by Region (2019-2024)
6.1.2 APAC Icodec Insulin Revenue by Region (2019-2024)
6.2 APAC Icodec Insulin Sales by Type (2019-2024)
6.3 APAC Icodec Insulin Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Icodec Insulin by Country
7.1.1 Europe Icodec Insulin Sales by Country (2019-2024)
7.1.2 Europe Icodec Insulin Revenue by Country (2019-2024)
7.2 Europe Icodec Insulin Sales by Type (2019-2024)
7.3 Europe Icodec Insulin Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Icodec Insulin by Country
8.1.1 Middle East & Africa Icodec Insulin Sales by Country (2019-2024)
8.1.2 Middle East & Africa Icodec Insulin Revenue by Country (2019-2024)
8.2 Middle East & Africa Icodec Insulin Sales by Type (2019-2024)
8.3 Middle East & Africa Icodec Insulin Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Icodec Insulin
10.3 Manufacturing Process Analysis of Icodec Insulin
10.4 Industry Chain Structure of Icodec Insulin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Icodec Insulin Distributors
11.3 Icodec Insulin Customer
12 WORLD FORECAST REVIEW FOR ICODEC INSULIN BY GEOGRAPHIC REGION
12.1 Global Icodec Insulin Market Size Forecast by Region
12.1.1 Global Icodec Insulin Forecast by Region (2025-2030)
12.1.2 Global Icodec Insulin Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Icodec Insulin Forecast by Type (2025-2030)
12.7 Global Icodec Insulin Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Icodec Insulin Product Portfolios and Specifications
13.1.3 Novo Nordisk Icodec Insulin Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Lilly
13.2.1 Lilly Company Information
13.2.2 Lilly Icodec Insulin Product Portfolios and Specifications
13.2.3 Lilly Icodec Insulin Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Lilly Main Business Overview
13.2.5 Lilly Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Icodec Insulin Product Portfolios and Specifications
13.3.3 Sanofi Icodec Insulin Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Paijin Biotechnology
13.4.1 Paijin Biotechnology Company Information
13.4.2 Paijin Biotechnology Icodec Insulin Product Portfolios and Specifications
13.4.3 Paijin Biotechnology Icodec Insulin Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Paijin Biotechnology Main Business Overview
13.4.5 Paijin Biotechnology Latest Developments
13.5 Gan&Lee Pharmaceuticals
13.5.1 Gan&Lee Pharmaceuticals Company Information
13.5.2 Gan&Lee Pharmaceuticals Icodec Insulin Product Portfolios and Specifications
13.5.3 Gan&Lee Pharmaceuticals Icodec Insulin Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Gan&Lee Pharmaceuticals Main Business Overview
13.5.5 Gan&Lee Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Icodec Insulin Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Icodec Insulin by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Icodec Insulin by Country/Region, 2019, 2023 & 2030
2.2 Icodec Insulin Segment by Type
2.2.1 Long-acting
2.2.2 Medium-acting
2.3 Icodec Insulin Sales by Type
2.3.1 Global Icodec Insulin Sales Market Share by Type (2019-2024)
2.3.2 Global Icodec Insulin Revenue and Market Share by Type (2019-2024)
2.3.3 Global Icodec Insulin Sale Price by Type (2019-2024)
2.4 Icodec Insulin Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Icodec Insulin Sales by Application
2.5.1 Global Icodec Insulin Sale Market Share by Application (2019-2024)
2.5.2 Global Icodec Insulin Revenue and Market Share by Application (2019-2024)
2.5.3 Global Icodec Insulin Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global Icodec Insulin Breakdown Data by Company
3.1.1 Global Icodec Insulin Annual Sales by Company (2019-2024)
3.1.2 Global Icodec Insulin Sales Market Share by Company (2019-2024)
3.2 Global Icodec Insulin Annual Revenue by Company (2019-2024)
3.2.1 Global Icodec Insulin Revenue by Company (2019-2024)
3.2.2 Global Icodec Insulin Revenue Market Share by Company (2019-2024)
3.3 Global Icodec Insulin Sale Price by Company
3.4 Key Manufacturers Icodec Insulin Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Icodec Insulin Product Location Distribution
3.4.2 Players Icodec Insulin Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ICODEC INSULIN BY GEOGRAPHIC REGION
4.1 World Historic Icodec Insulin Market Size by Geographic Region (2019-2024)
4.1.1 Global Icodec Insulin Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Icodec Insulin Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Icodec Insulin Market Size by Country/Region (2019-2024)
4.2.1 Global Icodec Insulin Annual Sales by Country/Region (2019-2024)
4.2.2 Global Icodec Insulin Annual Revenue by Country/Region (2019-2024)
4.3 Americas Icodec Insulin Sales Growth
4.4 APAC Icodec Insulin Sales Growth
4.5 Europe Icodec Insulin Sales Growth
4.6 Middle East & Africa Icodec Insulin Sales Growth
5 AMERICAS
5.1 Americas Icodec Insulin Sales by Country
5.1.1 Americas Icodec Insulin Sales by Country (2019-2024)
5.1.2 Americas Icodec Insulin Revenue by Country (2019-2024)
5.2 Americas Icodec Insulin Sales by Type (2019-2024)
5.3 Americas Icodec Insulin Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Icodec Insulin Sales by Region
6.1.1 APAC Icodec Insulin Sales by Region (2019-2024)
6.1.2 APAC Icodec Insulin Revenue by Region (2019-2024)
6.2 APAC Icodec Insulin Sales by Type (2019-2024)
6.3 APAC Icodec Insulin Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Icodec Insulin by Country
7.1.1 Europe Icodec Insulin Sales by Country (2019-2024)
7.1.2 Europe Icodec Insulin Revenue by Country (2019-2024)
7.2 Europe Icodec Insulin Sales by Type (2019-2024)
7.3 Europe Icodec Insulin Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Icodec Insulin by Country
8.1.1 Middle East & Africa Icodec Insulin Sales by Country (2019-2024)
8.1.2 Middle East & Africa Icodec Insulin Revenue by Country (2019-2024)
8.2 Middle East & Africa Icodec Insulin Sales by Type (2019-2024)
8.3 Middle East & Africa Icodec Insulin Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Icodec Insulin
10.3 Manufacturing Process Analysis of Icodec Insulin
10.4 Industry Chain Structure of Icodec Insulin
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Icodec Insulin Distributors
11.3 Icodec Insulin Customer
12 WORLD FORECAST REVIEW FOR ICODEC INSULIN BY GEOGRAPHIC REGION
12.1 Global Icodec Insulin Market Size Forecast by Region
12.1.1 Global Icodec Insulin Forecast by Region (2025-2030)
12.1.2 Global Icodec Insulin Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Icodec Insulin Forecast by Type (2025-2030)
12.7 Global Icodec Insulin Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk Icodec Insulin Product Portfolios and Specifications
13.1.3 Novo Nordisk Icodec Insulin Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 Lilly
13.2.1 Lilly Company Information
13.2.2 Lilly Icodec Insulin Product Portfolios and Specifications
13.2.3 Lilly Icodec Insulin Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Lilly Main Business Overview
13.2.5 Lilly Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Icodec Insulin Product Portfolios and Specifications
13.3.3 Sanofi Icodec Insulin Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Paijin Biotechnology
13.4.1 Paijin Biotechnology Company Information
13.4.2 Paijin Biotechnology Icodec Insulin Product Portfolios and Specifications
13.4.3 Paijin Biotechnology Icodec Insulin Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Paijin Biotechnology Main Business Overview
13.4.5 Paijin Biotechnology Latest Developments
13.5 Gan&Lee Pharmaceuticals
13.5.1 Gan&Lee Pharmaceuticals Company Information
13.5.2 Gan&Lee Pharmaceuticals Icodec Insulin Product Portfolios and Specifications
13.5.3 Gan&Lee Pharmaceuticals Icodec Insulin Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Gan&Lee Pharmaceuticals Main Business Overview
13.5.5 Gan&Lee Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Icodec Insulin Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Icodec Insulin Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Long-acting
Table 4. Major Players of Medium-acting
Table 5. Global Icodec Insulin Sales by Type (2019-2024) & (K Dose)
Table 6. Global Icodec Insulin Sales Market Share by Type (2019-2024)
Table 7. Global Icodec Insulin Revenue by Type (2019-2024) & ($ million)
Table 8. Global Icodec Insulin Revenue Market Share by Type (2019-2024)
Table 9. Global Icodec Insulin Sale Price by Type (2019-2024) & (US$/Dose)
Table 10. Global Icodec Insulin Sale by Application (2019-2024) & (K Dose)
Table 11. Global Icodec Insulin Sale Market Share by Application (2019-2024)
Table 12. Global Icodec Insulin Revenue by Application (2019-2024) & ($ million)
Table 13. Global Icodec Insulin Revenue Market Share by Application (2019-2024)
Table 14. Global Icodec Insulin Sale Price by Application (2019-2024) & (US$/Dose)
Table 15. Global Icodec Insulin Sales by Company (2019-2024) & (K Dose)
Table 16. Global Icodec Insulin Sales Market Share by Company (2019-2024)
Table 17. Global Icodec Insulin Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Icodec Insulin Revenue Market Share by Company (2019-2024)
Table 19. Global Icodec Insulin Sale Price by Company (2019-2024) & (US$/Dose)
Table 20. Key Manufacturers Icodec Insulin Producing Area Distribution and Sales Area
Table 21. Players Icodec Insulin Products Offered
Table 22. Icodec Insulin Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Icodec Insulin Sales by Geographic Region (2019-2024) & (K Dose)
Table 26. Global Icodec Insulin Sales Market Share Geographic Region (2019-2024)
Table 27. Global Icodec Insulin Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Icodec Insulin Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Icodec Insulin Sales by Country/Region (2019-2024) & (K Dose)
Table 30. Global Icodec Insulin Sales Market Share by Country/Region (2019-2024)
Table 31. Global Icodec Insulin Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Icodec Insulin Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Icodec Insulin Sales by Country (2019-2024) & (K Dose)
Table 34. Americas Icodec Insulin Sales Market Share by Country (2019-2024)
Table 35. Americas Icodec Insulin Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Icodec Insulin Sales by Type (2019-2024) & (K Dose)
Table 37. Americas Icodec Insulin Sales by Application (2019-2024) & (K Dose)
Table 38. APAC Icodec Insulin Sales by Region (2019-2024) & (K Dose)
Table 39. APAC Icodec Insulin Sales Market Share by Region (2019-2024)
Table 40. APAC Icodec Insulin Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Icodec Insulin Sales by Type (2019-2024) & (K Dose)
Table 42. APAC Icodec Insulin Sales by Application (2019-2024) & (K Dose)
Table 43. Europe Icodec Insulin Sales by Country (2019-2024) & (K Dose)
Table 44. Europe Icodec Insulin Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Icodec Insulin Sales by Type (2019-2024) & (K Dose)
Table 46. Europe Icodec Insulin Sales by Application (2019-2024) & (K Dose)
Table 47. Middle East & Africa Icodec Insulin Sales by Country (2019-2024) & (K Dose)
Table 48. Middle East & Africa Icodec Insulin Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Icodec Insulin Sales by Type (2019-2024) & (K Dose)
Table 50. Middle East & Africa Icodec Insulin Sales by Application (2019-2024) & (K Dose)
Table 51. Key Market Drivers & Growth Opportunities of Icodec Insulin
Table 52. Key Market Challenges & Risks of Icodec Insulin
Table 53. Key Industry Trends of Icodec Insulin
Table 54. Icodec Insulin Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Icodec Insulin Distributors @List
Table 57. Icodec Insulin Customer @List
Table 58. Global Icodec Insulin Sales Forecast by Region (2025-2030) & (K Dose)
Table 59. Global Icodec Insulin Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Icodec Insulin Sales Forecast by Country (2025-2030) & (K Dose)
Table 61. Americas Icodec Insulin Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Icodec Insulin Sales Forecast by Region (2025-2030) & (K Dose)
Table 63. APAC Icodec Insulin Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Icodec Insulin Sales Forecast by Country (2025-2030) & (K Dose)
Table 65. Europe Icodec Insulin Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Icodec Insulin Sales Forecast by Country (2025-2030) & (K Dose)
Table 67. Middle East & Africa Icodec Insulin Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Icodec Insulin Sales Forecast by Type (2025-2030) & (K Dose)
Table 69. Global Icodec Insulin Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Icodec Insulin Sales Forecast by Application (2025-2030) & (K Dose)
Table 71. Global Icodec Insulin Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Novo Nordisk Basic Information, Icodec Insulin Manufacturing Base, Sales Area and Its Competitors
Table 73. Novo Nordisk Icodec Insulin Product Portfolios and Specifications
Table 74. Novo Nordisk Icodec Insulin Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 75. Novo Nordisk Main Business
Table 76. Novo Nordisk Latest Developments
Table 77. Lilly Basic Information, Icodec Insulin Manufacturing Base, Sales Area and Its Competitors
Table 78. Lilly Icodec Insulin Product Portfolios and Specifications
Table 79. Lilly Icodec Insulin Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 80. Lilly Main Business
Table 81. Lilly Latest Developments
Table 82. Sanofi Basic Information, Icodec Insulin Manufacturing Base, Sales Area and Its Competitors
Table 83. Sanofi Icodec Insulin Product Portfolios and Specifications
Table 84. Sanofi Icodec Insulin Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 85. Sanofi Main Business
Table 86. Sanofi Latest Developments
Table 87. Paijin Biotechnology Basic Information, Icodec Insulin Manufacturing Base, Sales Area and Its Competitors
Table 88. Paijin Biotechnology Icodec Insulin Product Portfolios and Specifications
Table 89. Paijin Biotechnology Icodec Insulin Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 90. Paijin Biotechnology Main Business
Table 91. Paijin Biotechnology Latest Developments
Table 92. Gan&Lee Pharmaceuticals Basic Information, Icodec Insulin Manufacturing Base, Sales Area and Its Competitors
Table 93. Gan&Lee Pharmaceuticals Icodec Insulin Product Portfolios and Specifications
Table 94. Gan&Lee Pharmaceuticals Icodec Insulin Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 95. Gan&Lee Pharmaceuticals Main Business
Table 96. Gan&Lee Pharmaceuticals Latest Developments
Table 1. Icodec Insulin Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Icodec Insulin Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Long-acting
Table 4. Major Players of Medium-acting
Table 5. Global Icodec Insulin Sales by Type (2019-2024) & (K Dose)
Table 6. Global Icodec Insulin Sales Market Share by Type (2019-2024)
Table 7. Global Icodec Insulin Revenue by Type (2019-2024) & ($ million)
Table 8. Global Icodec Insulin Revenue Market Share by Type (2019-2024)
Table 9. Global Icodec Insulin Sale Price by Type (2019-2024) & (US$/Dose)
Table 10. Global Icodec Insulin Sale by Application (2019-2024) & (K Dose)
Table 11. Global Icodec Insulin Sale Market Share by Application (2019-2024)
Table 12. Global Icodec Insulin Revenue by Application (2019-2024) & ($ million)
Table 13. Global Icodec Insulin Revenue Market Share by Application (2019-2024)
Table 14. Global Icodec Insulin Sale Price by Application (2019-2024) & (US$/Dose)
Table 15. Global Icodec Insulin Sales by Company (2019-2024) & (K Dose)
Table 16. Global Icodec Insulin Sales Market Share by Company (2019-2024)
Table 17. Global Icodec Insulin Revenue by Company (2019-2024) & ($ millions)
Table 18. Global Icodec Insulin Revenue Market Share by Company (2019-2024)
Table 19. Global Icodec Insulin Sale Price by Company (2019-2024) & (US$/Dose)
Table 20. Key Manufacturers Icodec Insulin Producing Area Distribution and Sales Area
Table 21. Players Icodec Insulin Products Offered
Table 22. Icodec Insulin Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Icodec Insulin Sales by Geographic Region (2019-2024) & (K Dose)
Table 26. Global Icodec Insulin Sales Market Share Geographic Region (2019-2024)
Table 27. Global Icodec Insulin Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Icodec Insulin Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Icodec Insulin Sales by Country/Region (2019-2024) & (K Dose)
Table 30. Global Icodec Insulin Sales Market Share by Country/Region (2019-2024)
Table 31. Global Icodec Insulin Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Icodec Insulin Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Icodec Insulin Sales by Country (2019-2024) & (K Dose)
Table 34. Americas Icodec Insulin Sales Market Share by Country (2019-2024)
Table 35. Americas Icodec Insulin Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas Icodec Insulin Sales by Type (2019-2024) & (K Dose)
Table 37. Americas Icodec Insulin Sales by Application (2019-2024) & (K Dose)
Table 38. APAC Icodec Insulin Sales by Region (2019-2024) & (K Dose)
Table 39. APAC Icodec Insulin Sales Market Share by Region (2019-2024)
Table 40. APAC Icodec Insulin Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC Icodec Insulin Sales by Type (2019-2024) & (K Dose)
Table 42. APAC Icodec Insulin Sales by Application (2019-2024) & (K Dose)
Table 43. Europe Icodec Insulin Sales by Country (2019-2024) & (K Dose)
Table 44. Europe Icodec Insulin Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe Icodec Insulin Sales by Type (2019-2024) & (K Dose)
Table 46. Europe Icodec Insulin Sales by Application (2019-2024) & (K Dose)
Table 47. Middle East & Africa Icodec Insulin Sales by Country (2019-2024) & (K Dose)
Table 48. Middle East & Africa Icodec Insulin Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa Icodec Insulin Sales by Type (2019-2024) & (K Dose)
Table 50. Middle East & Africa Icodec Insulin Sales by Application (2019-2024) & (K Dose)
Table 51. Key Market Drivers & Growth Opportunities of Icodec Insulin
Table 52. Key Market Challenges & Risks of Icodec Insulin
Table 53. Key Industry Trends of Icodec Insulin
Table 54. Icodec Insulin Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Icodec Insulin Distributors @List
Table 57. Icodec Insulin Customer @List
Table 58. Global Icodec Insulin Sales Forecast by Region (2025-2030) & (K Dose)
Table 59. Global Icodec Insulin Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas Icodec Insulin Sales Forecast by Country (2025-2030) & (K Dose)
Table 61. Americas Icodec Insulin Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC Icodec Insulin Sales Forecast by Region (2025-2030) & (K Dose)
Table 63. APAC Icodec Insulin Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe Icodec Insulin Sales Forecast by Country (2025-2030) & (K Dose)
Table 65. Europe Icodec Insulin Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa Icodec Insulin Sales Forecast by Country (2025-2030) & (K Dose)
Table 67. Middle East & Africa Icodec Insulin Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global Icodec Insulin Sales Forecast by Type (2025-2030) & (K Dose)
Table 69. Global Icodec Insulin Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global Icodec Insulin Sales Forecast by Application (2025-2030) & (K Dose)
Table 71. Global Icodec Insulin Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Novo Nordisk Basic Information, Icodec Insulin Manufacturing Base, Sales Area and Its Competitors
Table 73. Novo Nordisk Icodec Insulin Product Portfolios and Specifications
Table 74. Novo Nordisk Icodec Insulin Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 75. Novo Nordisk Main Business
Table 76. Novo Nordisk Latest Developments
Table 77. Lilly Basic Information, Icodec Insulin Manufacturing Base, Sales Area and Its Competitors
Table 78. Lilly Icodec Insulin Product Portfolios and Specifications
Table 79. Lilly Icodec Insulin Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 80. Lilly Main Business
Table 81. Lilly Latest Developments
Table 82. Sanofi Basic Information, Icodec Insulin Manufacturing Base, Sales Area and Its Competitors
Table 83. Sanofi Icodec Insulin Product Portfolios and Specifications
Table 84. Sanofi Icodec Insulin Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 85. Sanofi Main Business
Table 86. Sanofi Latest Developments
Table 87. Paijin Biotechnology Basic Information, Icodec Insulin Manufacturing Base, Sales Area and Its Competitors
Table 88. Paijin Biotechnology Icodec Insulin Product Portfolios and Specifications
Table 89. Paijin Biotechnology Icodec Insulin Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 90. Paijin Biotechnology Main Business
Table 91. Paijin Biotechnology Latest Developments
Table 92. Gan&Lee Pharmaceuticals Basic Information, Icodec Insulin Manufacturing Base, Sales Area and Its Competitors
Table 93. Gan&Lee Pharmaceuticals Icodec Insulin Product Portfolios and Specifications
Table 94. Gan&Lee Pharmaceuticals Icodec Insulin Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 95. Gan&Lee Pharmaceuticals Main Business
Table 96. Gan&Lee Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Icodec Insulin
Figure 2. Icodec Insulin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Icodec Insulin Sales Growth Rate 2019-2030 (K Dose)
Figure 7. Global Icodec Insulin Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Icodec Insulin Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Icodec Insulin Sales Market Share by Country/Region (2023)
Figure 10. Icodec Insulin Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Long-acting
Figure 12. Product Picture of Medium-acting
Figure 13. Global Icodec Insulin Sales Market Share by Type in 2023
Figure 14. Global Icodec Insulin Revenue Market Share by Type (2019-2024)
Figure 15. Icodec Insulin Consumed in Hospital
Figure 16. Global Icodec Insulin Market: Hospital (2019-2024) & (K Dose)
Figure 17. Icodec Insulin Consumed in Clinic
Figure 18. Global Icodec Insulin Market: Clinic (2019-2024) & (K Dose)
Figure 19. Global Icodec Insulin Sale Market Share by Application (2023)
Figure 20. Global Icodec Insulin Revenue Market Share by Application in 2023
Figure 21. Icodec Insulin Sales by Company in 2023 (K Dose)
Figure 22. Global Icodec Insulin Sales Market Share by Company in 2023
Figure 23. Icodec Insulin Revenue by Company in 2023 ($ millions)
Figure 24. Global Icodec Insulin Revenue Market Share by Company in 2023
Figure 25. Global Icodec Insulin Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Icodec Insulin Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Icodec Insulin Sales 2019-2024 (K Dose)
Figure 28. Americas Icodec Insulin Revenue 2019-2024 ($ millions)
Figure 29. APAC Icodec Insulin Sales 2019-2024 (K Dose)
Figure 30. APAC Icodec Insulin Revenue 2019-2024 ($ millions)
Figure 31. Europe Icodec Insulin Sales 2019-2024 (K Dose)
Figure 32. Europe Icodec Insulin Revenue 2019-2024 ($ millions)
Figure 33. Middle East & Africa Icodec Insulin Sales 2019-2024 (K Dose)
Figure 34. Middle East & Africa Icodec Insulin Revenue 2019-2024 ($ millions)
Figure 35. Americas Icodec Insulin Sales Market Share by Country in 2023
Figure 36. Americas Icodec Insulin Revenue Market Share by Country (2019-2024)
Figure 37. Americas Icodec Insulin Sales Market Share by Type (2019-2024)
Figure 38. Americas Icodec Insulin Sales Market Share by Application (2019-2024)
Figure 39. United States Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 40. Canada Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 41. Mexico Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 42. Brazil Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 43. APAC Icodec Insulin Sales Market Share by Region in 2023
Figure 44. APAC Icodec Insulin Revenue Market Share by Region (2019-2024)
Figure 45. APAC Icodec Insulin Sales Market Share by Type (2019-2024)
Figure 46. APAC Icodec Insulin Sales Market Share by Application (2019-2024)
Figure 47. China Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 48. Japan Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 49. South Korea Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 50. Southeast Asia Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 51. India Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 52. Australia Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 53. China Taiwan Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 54. Europe Icodec Insulin Sales Market Share by Country in 2023
Figure 55. Europe Icodec Insulin Revenue Market Share by Country (2019-2024)
Figure 56. Europe Icodec Insulin Sales Market Share by Type (2019-2024)
Figure 57. Europe Icodec Insulin Sales Market Share by Application (2019-2024)
Figure 58. Germany Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 59. France Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 60. UK Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 61. Italy Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 62. Russia Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 63. Middle East & Africa Icodec Insulin Sales Market Share by Country (2019-2024)
Figure 64. Middle East & Africa Icodec Insulin Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa Icodec Insulin Sales Market Share by Application (2019-2024)
Figure 66. Egypt Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 67. South Africa Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 68. Israel Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 69. Turkey Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 70. GCC Countries Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Icodec Insulin in 2023
Figure 72. Manufacturing Process Analysis of Icodec Insulin
Figure 73. Industry Chain Structure of Icodec Insulin
Figure 74. Channels of Distribution
Figure 75. Global Icodec Insulin Sales Market Forecast by Region (2025-2030)
Figure 76. Global Icodec Insulin Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global Icodec Insulin Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global Icodec Insulin Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global Icodec Insulin Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global Icodec Insulin Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Icodec Insulin
Figure 2. Icodec Insulin Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Icodec Insulin Sales Growth Rate 2019-2030 (K Dose)
Figure 7. Global Icodec Insulin Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. Icodec Insulin Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. Icodec Insulin Sales Market Share by Country/Region (2023)
Figure 10. Icodec Insulin Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Long-acting
Figure 12. Product Picture of Medium-acting
Figure 13. Global Icodec Insulin Sales Market Share by Type in 2023
Figure 14. Global Icodec Insulin Revenue Market Share by Type (2019-2024)
Figure 15. Icodec Insulin Consumed in Hospital
Figure 16. Global Icodec Insulin Market: Hospital (2019-2024) & (K Dose)
Figure 17. Icodec Insulin Consumed in Clinic
Figure 18. Global Icodec Insulin Market: Clinic (2019-2024) & (K Dose)
Figure 19. Global Icodec Insulin Sale Market Share by Application (2023)
Figure 20. Global Icodec Insulin Revenue Market Share by Application in 2023
Figure 21. Icodec Insulin Sales by Company in 2023 (K Dose)
Figure 22. Global Icodec Insulin Sales Market Share by Company in 2023
Figure 23. Icodec Insulin Revenue by Company in 2023 ($ millions)
Figure 24. Global Icodec Insulin Revenue Market Share by Company in 2023
Figure 25. Global Icodec Insulin Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Icodec Insulin Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Icodec Insulin Sales 2019-2024 (K Dose)
Figure 28. Americas Icodec Insulin Revenue 2019-2024 ($ millions)
Figure 29. APAC Icodec Insulin Sales 2019-2024 (K Dose)
Figure 30. APAC Icodec Insulin Revenue 2019-2024 ($ millions)
Figure 31. Europe Icodec Insulin Sales 2019-2024 (K Dose)
Figure 32. Europe Icodec Insulin Revenue 2019-2024 ($ millions)
Figure 33. Middle East & Africa Icodec Insulin Sales 2019-2024 (K Dose)
Figure 34. Middle East & Africa Icodec Insulin Revenue 2019-2024 ($ millions)
Figure 35. Americas Icodec Insulin Sales Market Share by Country in 2023
Figure 36. Americas Icodec Insulin Revenue Market Share by Country (2019-2024)
Figure 37. Americas Icodec Insulin Sales Market Share by Type (2019-2024)
Figure 38. Americas Icodec Insulin Sales Market Share by Application (2019-2024)
Figure 39. United States Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 40. Canada Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 41. Mexico Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 42. Brazil Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 43. APAC Icodec Insulin Sales Market Share by Region in 2023
Figure 44. APAC Icodec Insulin Revenue Market Share by Region (2019-2024)
Figure 45. APAC Icodec Insulin Sales Market Share by Type (2019-2024)
Figure 46. APAC Icodec Insulin Sales Market Share by Application (2019-2024)
Figure 47. China Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 48. Japan Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 49. South Korea Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 50. Southeast Asia Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 51. India Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 52. Australia Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 53. China Taiwan Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 54. Europe Icodec Insulin Sales Market Share by Country in 2023
Figure 55. Europe Icodec Insulin Revenue Market Share by Country (2019-2024)
Figure 56. Europe Icodec Insulin Sales Market Share by Type (2019-2024)
Figure 57. Europe Icodec Insulin Sales Market Share by Application (2019-2024)
Figure 58. Germany Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 59. France Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 60. UK Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 61. Italy Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 62. Russia Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 63. Middle East & Africa Icodec Insulin Sales Market Share by Country (2019-2024)
Figure 64. Middle East & Africa Icodec Insulin Sales Market Share by Type (2019-2024)
Figure 65. Middle East & Africa Icodec Insulin Sales Market Share by Application (2019-2024)
Figure 66. Egypt Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 67. South Africa Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 68. Israel Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 69. Turkey Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 70. GCC Countries Icodec Insulin Revenue Growth 2019-2024 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Icodec Insulin in 2023
Figure 72. Manufacturing Process Analysis of Icodec Insulin
Figure 73. Industry Chain Structure of Icodec Insulin
Figure 74. Channels of Distribution
Figure 75. Global Icodec Insulin Sales Market Forecast by Region (2025-2030)
Figure 76. Global Icodec Insulin Revenue Market Share Forecast by Region (2025-2030)
Figure 77. Global Icodec Insulin Sales Market Share Forecast by Type (2025-2030)
Figure 78. Global Icodec Insulin Revenue Market Share Forecast by Type (2025-2030)
Figure 79. Global Icodec Insulin Sales Market Share Forecast by Application (2025-2030)
Figure 80. Global Icodec Insulin Revenue Market Share Forecast by Application (2025-2030)
